Clinical Trial Update: CVD Risk and Health in Postmenopausal Phytoestrogen Users [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cardiovascular risk and overall health in postmenopausal users of phytoestrogens has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Major Depressive Disorder
• Myocardial Ischemia
• Osteoporosis

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Bone Diseases, Cardiovascular Diseases | Phase 2 | Status: COMPLETED